SYNCRIP and pancreatic adenocarcinoma: Targets of GTF3C1 and SYNCRIP, both of which are upregulated in metastatic pancreatic tumors compared to primary tumors, were also significantly increased in expression in high-ColX module gender-specific PAAD cohorts.